# Primary Cervical Cancer Screening by Self-sampling HPV Test

> **NCT05613283** · — · ACTIVE_NOT_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 17875 (estimated)

## Conditions studied

- Human Papillomavirus Infection
- Cervical Cancer
- Negative For Intraepithelial Lesion Or Malignancy
- Atypical Squamous Cells of Undetermined Significance
- Atypical Squamous Cells, Cannot Rule Out High-grade Squamous Intraepithelial Lesion
- Cervical Squamous Intraepithelial Lesion
- Low-Grade Squamous Intraepithelial Lesions
- High-Grade Squamous Intraepithelial Lesions
- Cervical Intraepithelial Neoplasia Grade I
- Cervical Intraepithelial Neoplasia Grade II
- Cervical Intraepithelial Neoplasia, Grade III
- Atypical Glandular Cells
- Atypical Glandular Cells Not Otherwise Specified
- Atypical Glandular Cells, Favor Neoplastic
- Cervical Squamous Cell Carcinoma
- Adenocarcinoma in Situ
- Cervical Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05613283
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-19
- **Primary completion:** 2026-07
- **Final completion:** 2027-08-31
- **Target enrollment:** 17875 (ESTIMATED)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05613283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05613283, "Primary Cervical Cancer Screening by Self-sampling HPV Test". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05613283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*